Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 190.03M P/E - EPS this Y 47.10% Ern Qtrly Grth -
Income -37.88M Forward P/E -3.80 EPS next Y - 50D Avg Chg 31.00%
Sales 2.2M PEG - EPS past 5Y - 200D Avg Chg 71.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -5.00%
Recommedations 1.00 Quick Ratio 0.10 Shares Outstanding 13.68M 52W Low Chg 169.00%
Insider Own 2.00% ROA -179.75% Shares Float 13.40M Beta 1.90
Inst Own 23.59% ROE - Shares Shorted/Prior 684.58K/815K Price 1.56
Gross Margin - Profit Margin - Avg. Volume 731,461 Target Price 120.00
Oper. Margin -1,226.80% Earnings Date May 13 Volume 802,583 Change -1.27%
About Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York.

Seelos Therapeutics, Inc. News
03/19/24 UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study
03/19/24 Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose)
01/26/24 Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
01/22/24 Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002
01/09/24 Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
01/02/24 Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024
12/29/23 11 Best Psychedelic Stocks to Buy in 2024
12/22/23 Seelos Therapeutics, Inc. Releases Letter to its Stockholders
12/20/23 11 Most Promising Psychedelic Stocks According to Hedge Funds
12/04/23 Insider Spends US$100k Buying More Shares In Seelos Therapeutics
12/02/23 Insider Buying: CFO Michael Golembiewski Acquires 83,000 Shares of Seelos Therapeutics Inc (SEEL)
12/01/23 Seelos Therapeutics Announces Closing of Public Offering
11/28/23 Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
11/28/23 Seelos Therapeutics Announces Proposed Public Offering
11/27/23 Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)
11/24/23 Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
10/27/23 Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023
10/17/23 Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations
09/27/23 Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease
06:00 AM Weekly Roundup on the Cannabis Sector & Psychedelic Sector
SEEL Chatroom

User Image JackNapier22 Posted - 9 minutes ago

$SEEL who remembers ”nobody would answer the phone but they are answering now…?” that was september

User Image fishmarket Posted - 35 minutes ago

@TravisKaleSea I remember once I wrote an email to former CEO of GM and he answered me. Imagine the CEO of GM is accessible but the CEO of a microcap biotech company is not. No e-mail or phone. I don't even know if he's still alive. Same for Tony. Didn't return my message and e-mail from one month ago. I understand they have certain limitation because of regulation but up to a certain extent, people desserve respect. Just answer and say we cannot comment for now or some kind of answer. Someone told me once that Anthony was a complete road block for $SEEL and I think he was right.

User Image TravisKaleSea Posted - 38 minutes ago

$SEEL remember when he was blabbering about Parkinsons? These criminals made this mess on purpose. They will sell this company for a penny on the dollar and will start their scamming of new batch of hopeful investors under a different name. https://www.cgtlive.com/view/raj-mehra-phd-krishna-subramanian-phd-striving-disease-modifying-therapies-parkinson-disease

User Image TravisKaleSea Posted - 45 minutes ago

$SEEL biggest red flag.

User Image TravisKaleSea Posted - 1 hour ago

$SEEL STAY AS FAR AWAY FROM THIS FOLKS

User Image TravisKaleSea Posted - 1 hour ago

$SEEL Looking forward to the day this POS gets delisted

User Image TravisKaleSea Posted - 2 hours ago

$SEEL The Steve Jobs thing was an obvious red flag that I missed as well. This guy is a fucking criminal and similar to Liz Holmes belongs to behind the bar. I know you are reading this Tony. You are an accomplice.

User Image fishmarket Posted - 2 hours ago

$SEEL is Raj will step to plate like when he did to write a nice letter to us last december. They were allover us then. Now big silence. Anthony will say: no we cannot say anything to influence the price of a stock. I just can talk about data. So explain to me what just did Musk this week with $TSLA .

User Image TravisKaleSea Posted - 2 hours ago

$SEEL I hope they put these people behind the bars.

User Image EJBBBBB Posted - 2 hours ago

$SEEL Market cap under $4m lol. what a piece of shit! Good job Raj - truly doing God’s work

User Image fishmarket Posted - 3 hours ago

@MikeyNJ the fact that $SEEL did a rs gave a sign that the company was in distress. Investors are avoiding as much risk as possible which biotech sector + company in distress = avoid. In that kind of environnement it is pretty difficult to raise cash. Your results have to be stellar which was not with SLS-005. So there is SLS-002 going forward. As of now, it's in the hand of a Nasdaq decision. I don't see much catalyst soon. GLTA

User Image JackNapier22 Posted - 4 hours ago

$SEEL maybe it’ll just go to zero with no announcement at all. would be a fitting end

User Image BagholderDisinfectant Posted - 13 hours ago

$SEEL When I hear someone lost it all investing here:

User Image MikeyNJ Posted - 17 hours ago

$SEEL One last thought in respect to this nonsensical saga. What can it possibly cost to supply approximately 300 units of 002 and placebo for the DoD trial? Let's make a guestimate and say $300 each which is probably above the actual cost. That's a total cost of less than $100,000. Any of us could put up the money to supply the trial drug/placebo. I guess my conclusion is that if SEEL just vanishes into the ether and 002 never sees the light of day, then obviously it was never what they portrayed it to be.

User Image jnhall1960 Posted - 18 hours ago

$SEEL Going to great lengths to control the price. Ten trades from .3043 to .3060 here in red that equal exactly 100 shares and brought price to exactly $.30

User Image TravisKaleSea Posted - 18 hours ago

$SEEL Up BIG in afterhours Anthony. Time for you and Raj to take a WELL EARNED vacation.

User Image MikeyNJ Posted - 18 hours ago

$SEEL The one thing I took away from my last conversation with Anthony, is that the DoD 002 PTSD trial cannot go forward unless SEEL is an ongoing concern since SEEL would be responsible for supplying 002. So, SEEL has a fully funded trial that can possibly lead to an NDA and they will throw it all away because they can't come up with enough funding to supply product? In reality, they don't need any employees. Their only cost to stay in the game is to pay the costs for manufacturing and supplying 002! They can't come up with a few million to see this through? This has to be the craziest stock related story I have ever seen.

User Image SeelFudgedMe Posted - 19 hours ago

$SEEL our bags disappears for good next week

User Image fishmarket Posted - 21 hours ago

$SEEL $AMLX is down 87 %. Last week the CEO and the CFO bought some stocks. So even if their product failed, they are sitting on alot of cash because they managed like professional and they think they can turn this around. What about our CEO and CFO at $SEEL ?

User Image EJBBBBB Posted - 21 hours ago

$SEEL I think Tony was just demoted to Chief Non-Communications Officer…not a peep from this idiot ever.

User Image TravisKaleSea Posted - 21 hours ago

$SEEL For almost a month this piece of fucking shit has been at the bottom of my watchlist, down 10% each day. And that fucking coward, Anthony, and his boss Raj, just sitting there watching. You are a coward Anthony.

User Image mamamamama Posted - 21 hours ago

$SEEL so a 99 percent loss for investors what d bags

User Image EJBBBBB Posted - 22 hours ago

$SEEL under a penny! What complete douchebags. Thanks Raj and Tony! Go ruin another company

User Image JackNapier22 Posted - 23 hours ago

$SEEL literally just bleeding out in silence - not sure i have ever seen that before

User Image Stocktelligence Posted - 23 hours ago

$SEEL

User Image fishmarket Posted - 23 hours ago

$SEEL so @WillTryToBustSomeMyths , what's your take here ?

User Image Stocktelligence Posted - 23 hours ago

$SEEL

User Image fishmarket Posted - 1 day ago

$SEEL Raj has really have to step up here. Was suppose to be an historic year but so far is not. A conference call to make the point is overdue here.

User Image lipz2lipz3 Posted - 1 day ago

$SEEL

User Image ThreeHornedBull Posted - 1 day ago

$SEEL sell 002 for anything…

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Mehra Raj See Remarks See Remarks Mar 31 Buy 0.8526 66,667 56,840 3,281,546 03/31/22